Bionano Genomics (BNGO) executive compensation, 2026 proxy

R. Erik Holmlin, Ph.D., Chief Executive Officer, was paid $1.1M in 2025, up 12% from $989,677 the year before.

Filed
April 2, 2026
Annual meeting
May 14, 2026
Pay year
2025
Named executives
3
CEO total pay
$1.1M+12% vs prior year
CEO pay in equity
46%$512,742 in awards
Prior say-on-pay support
53%of votes cast
2025 CEO Total Compensation
$1,112,742Increase from prior year total.
Say-on-Pay Support
53.3%Support at 2025 annual meeting.
Corporate Goal Achievement
112.67%Achieved target percentage for 2025.

How Ph.D. was paid

$1.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary54%Stock awards5%Option awards41%

Named executive officers

ExecutiveTotal
R. Erik Holmlin, Ph.D.Chief Executive Officer$1,112,742
Mark OldakowskiChief Operating Officer$756,329
Alka Chaubey, Ph.D., FACMGChief Medical Officer$756,329

What changed and why

  • $1.1MChief executive officer total compensation increased to $1,112,742 for fiscal year 2025.
  • Base salaries for named executive officers remained unchanged from 2024 levels.
  • 112.67%Corporate performance achieved 112.67% of target across four categories.
  • Performance-based bonuses were awarded to executives based on funding and goal achievement.
  • 53.3%Previous say-on-pay support was approximately 53.3% of votes cast.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.